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Abstract We demonstrate the use of surface Zeta potential
measurements as a new tool to investigate the interactions
of iron oxide nanoparticles and cowpea mosaic virus
(CPMV) nanoparticles with human normal breast epithelial
cells (MCF10A) and cancer breast epithelial cells (MCF7)
respectively. A substantial understanding in the interaction
of nanoparticles with normal and cancer cells in vitro will
enable the capabilities of improving diagnostic and treat-
ment methods in cancer research, such as imaging and
targeted drug delivery. A theoretical Zeta potential model is
first established to show the effects of binding process and
internalization process during the nanoparticle uptake by
cells and the possible trends of Zeta potential change is
predicted for different cell endocytosis capacities. The
corresponding changes of total surface charge of cells in
the form of Zeta potential measurements were then reported
after incubated respectively with iron oxide nanoparticles
and CPMV nanoparticles. As observed, after MCF7 and
MCF10A cells were incubated respectively with two types
of nanoparticles, the significant differences in their surface
charge change indicate the potential role of Zeta potential
as a valuable biological signature in studying the cellular
Biomed Microdevices (2008) 10:321–328
DOI 10.1007/s10544-007-9139-2
Y. Zhang : C. S. Ozkan (*)
Department of Mechanical Engineering,
University of California at Riverside,





Department of Health Technology and Informatics,
Hong Kong Polytechnic University,




University of California at Riverside,
Riverside, CA 92521, USA
e-mail: nportney@engr.ucr.edu
D. Cui






Gurer Budak Faculty of Medicine,











Department of Electrical Engineering,
University of California at Riverside,
Riverside, CA 92521, USA
e-mail: mihri@ee.ucr.edu
interaction of nanoparticles, as well as specific cell
functionality.
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1 Introduction
Zeta potential measurements provide an important criterion
for the stability of a colloid system (Hunter 1981). In cell
biology, the concept of Zeta potential has been used to
study cell biological activation, cell agglutination and cell
adhesion which are related to cell surface charge properties
(Veronesi et al. 2002; Fontes et al. 2006; Lin et al. 2006). In
particular, Altankov et al. stated that the Zeta potential
might be a critical parameter for cellular interaction
(Altankov et al. 2003). Although Zeta potential measure-
ments have been utilized in probing the interaction between
cells and biomolecules, it still remains an untapped method
for studying the interaction between nanoparticles and
biological cells. In this study, we use Zeta potential
measurements to probe the surface charge responses of
normal breast epithelial cells (MCF10A) and cancer breast
epithelial cells (MCF7) during iron oxide nanoparticle and
CPMV nanoparticle endocytosis respectively.
Iron oxide and CPMV nanoparticles are the commonly
investigated nanoparticles for current cancer therapeutics
and diagnosis. Magnetic nanoparticles, especially iron
oxide nanoparticles including magnetite Fe3O4 and maghe-
mite (γ-Fe2O3) have been widely studied for their potential
applications in a variety of biomedical fields for their
unique physical, chemical and magnetic properties (Gupta
and Gupta 2005; Berry and Curtis 2003). They are non-
toxic, biocompatible (Perez et al. 2002; Dyal et al. 2003)
and have been widely used in magnetic resonance imaging
(MRI) contrast agents (Lee et al. 2006; Babes et al. 1999),
hyperthermia therapy (Hergt et al. 1998; Pardoe et al. 2003;
Sonvico et al. 2005) and targeted drug delivery (Gupta and
Wells 2004; Alexiou et al. 2000; Jain et al. 2005). Cowpea
mosaic virus (CPMV) is one of the smallest plant viruses,
which is an icosahedron with a spherical average diameter
of 28.4 nm that built from 60 copies of two asymmetric
protein units assembled around a single-stranded bipartite
RNA genome (Lewis et al. 2006; Blum et al. 2004). Its
highly organized nanoblock structure, chemically address-
able sites on the protein shell (the capsid) surface, and pH
and thermally stability over a wide range of conditions
make CPMV an excellent choice in biomedical applications
including vaccines, vascular imaging, and targeted drug
delivery (Lewis et al. 2006; Koudelka et al. 2007;
Manchester et al. 2006; Lomonossoff et al. 1999).
Cellular interaction of nanoparticles is one of the big
interests in their current biomedical applications. In our
study, we observed the distinct changes in Zeta potential
measurements of normal breast epithelial cells (MCF10A)
and cancer breast epithelial cells (MCF7) after incubated
with iron oxide nanopaticles and CPMV nanoparticles
respectively. Those changes in Zeta potential values are
relative to cell surface charge, nanoparticle surface charge
and the interaction between cells and nanoparticles. Our
results suggest that Zeta potential is a feasible tool for
probing the biological signature in describing the interac-
tion between cells and nanoparticles.
2 Materials and methods
2.1 Cell culture and sample preparation
MCF7 cancer breast epithelial cells and MCF10A normal
breast epithelial cells were purchased from American Type
Culture Collection (ATCC). MCF10A cells were grown in
Mammary Epithelial Cell Medium (Cambrex) supple-
mented with 100 ng/ml cholera toxin. MCF7 cells were
grown in Dulbecco’s Modified Eagle’s Medium supple-
mented with 10% fetal bovine serum, 5% Penicillin
Streptomycin Glutamine and 5% Sodium Pyruvate. Cells
were all cultured at 37°C in a humidified and 5% CO2
atomosphere until grown to the desired density in 25 cm2
flasks.
The magnetic iron oxide nanoparticles (maghemite γ-
Fe2O3) in this study were purchased from Alfa Aesar and
used without further modification. The average diameter of
iron oxide nanoparticle is around 30 nm. Purified CPMV-
T184C mutant type viral nanoparticles were kindly provided
by Dr. Manchester in Scripps Research Institute. Figure 1
shows the Transmission Electron Micrographs of these two
nanoparticles. 50 µg/ml iron oxide and CPMV nanoparticles
were incubated with MCF7 cancer breast epithelial cells and
MCF10A normal breast epithelial cells separately in 25 cm2
flask at 37°C in a humidified and 5% CO2 atomosphere for
specified time periods of 30 min, 4 and 24 h. After the
incubation procedure, cells were washed with Dulbecco’s
Fig. 1 TEM micrographs of iron oxide nanoparticles (a) and CPMV
nanoparticle (b). The length of scale bar is 30 nm
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Phosphate Buffered Saline (DPBS) for three times. MCF10A
cells were lifted off using Typsin-EDTA and MCF 7 cells
were lifted off using Cell dissociation buffer (from Invitro-
gen). After that, they were pelleted down and suspended into
Hepes buffer for Zeta potential measurements.
2.2 Zeta potential measurements
The Zeta (ξ) potential is the electrostatic potential that
exists at the shear plane of a particle, which is related to
both surface charge and the local environment of the
particle. The Zeta potential of our samples was determined
with a Zeta Potential Analyzer from Brookhaven Instru-
ments Corporation. Measurements were recorded at 25°C
suspended in Hepes buffer (ionic strength 40 mM, pH 7.4)
with a Ag electrode using Phase Analysis Light Scattering
mode. The Zeta (ξ) potential was automatically calculated
from electrophoretic mobility based on the Smoluchowski
equation, v=(εE/η)ξ, where v is the measured electropho-
retic velocity, η is the viscosity, ε is the electrical
permittivity of the electrolytic solution and E is the electric
field.
2.3 Transmission electron microscopy (TEM)
MCF7 and MCF10A cells were cultured on Thermanox
plastic cover slips and then incubated with 50 μg/ml iron
oxide nanoparticles and CPMV nanoparticles respectively
for 30 min, 4 and 24 h. After rinsed with DPBS for three
times, the cells were rinsed with 0.1 M Sodium cacodylate,
fixed in 2% Gluteraldahyde in the same buffer, and
followed by post fixed with 1% osmium tetroxode. After
dehydrated using an increasing graded ethanol series, the
cells were embedded in Spuur resin. Then the specimens
were sectioned by a Sorvall MT2 Ultramicrotome and post-
stained with uranyl acetate and lead citrate. The slides were
viewed using a TEM Tecnai12 at Central Facility for
Advanced Microscopy and Microanalysis (CFAMM) in the
University of California, Riverside. CPMV nanoparticles
alone were imaged using TEM Tecnai 12 on plasma
oxidized carbon on copper support TEM grids after stained
by uranyl acetate.
3 Theory and analysis
When nanoparticles are adsorbed at the cell surface they
may influence the Zeta potential by (1) influencing the
adsorption characteristics of the ions present; (2) shifting
the position of the plane of shear from the particle surface.
The analysis of this model is given in terms of a parameter
β(x) which measures how the presence of the nanoparticles
affects the free energy of the ions at a distance from the cell
surface. The additional free energy is incorporated into the
Boltzmann equation (Hunter 1981) so that






where ni is the number of ions of type i per unit volume in
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; ", is the permittivity.
Solving Eq. 3 and also using the charge balance in the









Where Q is cell surface charge, a is the radius of cell.
The potential at the shipping plane surface r ¼ aþ 1=κ
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For cell, the radius a is much larger than the double layer







Substituting Eq. 1 into the Poisson–Boltzmann Eq. 2, we




















Equation 7 is then solved in the Debye–Huckel
approximation with β(x)=β (a constant). The assumption
here is that the nanoparticle is uniformly distributed in the
cell interface.
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We get the similar expression of potential distribution
and zeta potential is the potential at the shipping plane










The relative zeta potential Z ¼ ζβ

ζ0comes out to be:




The process of nanoparticle uptake by cells could be
considered as composing of two steps: (a) the binding of
nanoparticles to the cell surface and (b) the internalization
of nanoparticles by specific endocytosis pathway. Here, β is
positive, i.e. Z>1 when nanoparticles bind onto the cell
surface with same sign of Zeta potential which increases the
free energy of the ions at a distance from the cell surface; β
is negative, i.e. Z<1 during the internalization of nano-
particles by the endocytosis pathway which decreases the
surface charge and shift the position of the plane of shear.
The relative Zeta potential of cells during the uptake of
nanoparticles can be expressed as:
Z ¼ exp mbinding 
βbinding
2
 mint  βint2
 
ð10Þ
Where mbinding is the total mass of nanoparticles
adsorbed to the cell surface; mint is the total mass of
nanoparticles internalized within the cell. Both the binding
and internalization processes can be modeled using Lang-
muir adsorption (Wilhelm et al. 2002):
dmintðtÞ
dt






¼ kiðφ0  φintðtÞÞmbindingðtÞ ð12Þ
dφintðtÞ
dt
¼ kiðφ0  φintðtÞÞ ð13Þ
Where m(t) is the mass of nanoparticles which is bound
to the cell surface, C is the nanoparticles concentration, m0
is the initial nanoparticle mass in the medium, ka is the
adsorption rate, kd is the desorption rate, φint is the fraction
of the reactive surface being internalized, φ0 is the
maximum fraction of reactive surfaces, and ki is the
internalization constant. The set of differential equations
(11–13) can be solved numerically.
Figure 2 illustrates the theoretical evaluation of Zeta
potential change with time under the effect of binding and
internalization processes. When the binding effect domi-
nates the whole uptake process, the Zeta potential increases
with the time until it reaches the saturation region (Fig. 2
(a)).When the internalization effect plays the most impor-
tant role during the uptake, the Zeta potential decreases
with time (Fig. 2 (b)). It has been reported that the
endocytosis capacity is pretty cell specific (Wilhelm et al.
2002). The cancer cells have comparatively a reduced
endocytosis capacity. So naturally, it is expected that the
Zeta potential for normal cells and cancer cells will have
different trends during the nanoparticles uptake process.
Fig. 2 Theoretical evaluation of Zeta potential vs. time for different
nanoparticles adsorption process: (a) the binding effect is larger than
internalization effect; (b) the binding effect is smaller than internal-
ization effect
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4 Results and discussion
Figure 3 shows the experimental results of Zeta potential
measurements at pH 7.4 for MCF7 cancer breast epithelial
cells alone, MCF10A normal breast epithelial cells alone,
iron oxide nanoparticles alone, CPMV nanoparticles alone
as well as two types of cells after incubated with two
different nanoparticles respectively for different time
lengths of 30 min, 4 and 24 h. For MCF10A normal cells
alone, the Zeta potential was −31.16±1.12 mV, which was
much more negative compared to that of −20.32±2.43 mV
for MCF7 cancer cells. This significant difference in
surface electrokinetic properties between normal and trans-
formed cancer cells has been reported before (Cook and
Jacobson 1968). For iron oxide nanoparticles alone, the
Zeta potential was −40.91±0.14 mV indicating good
dispersion stability. For CPMV nanoparticles alone, the
Zeta potential was −13.45±2.81 mV, which is within the
range of dielectric properties of CPMV reported by
Ermolina et al. (2006). The results of Zeta potential
measurements of MCF7 and MCF10A cells after incubated
with two different kinds of nanoparticles are very interest-
ing. Figure 3(a) shows the Zeta potential value of
MCF10A cells after incubated with iron oxide nanoparticles
slightly increased from −31.16±1.12 mV to −30.47±
0.15 mV after 30 min of incubation. This trend continued
as the Zeta potential value became −28.05±0.91 mV after
4 h incubation and −27.05 mV±0.47 mV after 24 h of
incubation. Figure 3(b) shows that for MCF7 cells, the
Zeta potential value changed in the opposite way after they
were incubated with iron oxide nanoparticles. The Zeta
potential value dropped significantly from −20.32±
2.43 mV to −25.17±0.52 mV after the first 30 min of
incubation and became −24.63±0.67 mV after 4 h of
incubation and further dropped to −26.55±0.78 mV after
24 h of incubation. The Zeta potential values after
incubation with iron oxide nanoparticles turned out to
change in opposite ways for cancer cells (MCF7) compared
to normal cells (MCF10A). In the case of CPMV nano-
particles, Fig. 3(c) shows that the change of Zeta potential
values of MCF10A cells after incubated with CPMV
nanoparticles also increased slightly from −31.16±
1.12 mV to −29.93±0.88 mV after 30 min of incubation,
and kept this tendency to −29.31±0.28 mV after 4 h
incubation and to −25.49 mV±2.11 mV after 24 h of
incubation. For MCF7 cells, Fig. 3(d) shows that the Zeta
potential value again changed in contrary to MCF10A cells
after they were incubated with CPMV nanoparticles. The
Zeta potential value dropped significantly from −20.32±
2.43 mV to −24.51±0.73 mV after the first 30 min, became
Fig. 3 These bar graphs show the results of Zeta Potential measure-
ments for normal breast epithelial cell (MCF10A), cancer breast
epithelial cell (MCF7), iron oxide nanoparticles, CPMV nanoparticles,
as well as the changes in the zeta potential values of cells after
incubated with these two types of nanoparticles. All the zeta potential
were measured using a ZetaPALS system in Hepes buffer (ionic
strength 40 mM, pH 7.4). (a) Comparison of Zeta Potential values of
iron oxide nanoparticles alone, MCF10A cells alone, and MCF10A
cells after incubated with iron oxide nanoparticles for 30 min, 4 and
24 h at 37°C; (b) Comparison of Zeta Potential values of iron oxide
nanoparticles alone, MCF7 cells alone and MCF7 cells after incubated
with iron oxide nanoparticles for 30 min, 4 and 24 h at 37°C; (c)
Comparison of zeta potential values of CPMV nanoparticles alone,
MCF10A cells alone and MCF10A cells after incubated with CPMV
nanoparticles for 30 min, 4 and 24 h; (d) Comparison of zeta potential
values of CPMV nanoparticles alone, MCF7 cells alone, and MCF7
cells after incubated with CPMV nanoparticles for 30 min, 4 and 24 h.
Note: On the bar graph, IO stands for iron oxide nanoparticles and the
error bar indicates the standard error for 8 runs of Zeta Potential
measurements
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−25.44±0.31 mV after 4 h and further dropped to −26.29±
0.46 mV after 24 h. In summary, the Zeta potential change
differences between MCF7 cells and MCF10A cells are
distinct after incubated with nanoparticles. However,
similar patterns occurred for the same type of cell after
incubated with two different nanoparticles.
As we mentioned before, the nanoparticle uptake by
cells could be considered as a binding process followed by
an internalization process. The possible mechanism for the
opposite trends of Zeta potential change between normal
cells and cancer cells could be explained by the following
reasons. First, the binding of charged nanoparticles to the
cell surface plasma membrane will change the Zeta
potential value of the cells. Zeta potential has been used
to diagnose the cellular interaction with charged ions or
molecules and the results showed that negatively charged
ions or molecules will decrease the surface Zeta potential
and positively charged ions will increase the surface Zeta
potential (Altankov et al. 2003; Siliva Filho et al. 1987). As
the Zeta potential value of nanoparticles we used in this
study were all negative, attachment of anionic nanoparticles
on the cell plasma membrane will cause the Zeta potential
to become intuitively more negative. The internalization
process resulting in the change of Zeta potential may be due
to the vesicular transport based cell endocytosis. During
endocytosis, cells uptake external substances by invaginat-
ing a small portion of the surface plasma membrane to form
a new intracellular vesicle around the substance to transport
inside the cells (Cooper 2000). Since the cell membrane is
overall negatively charged (Coleman and Finean 1968), the
loss of negatively charged cell membrane during vesicular
transport and negatively charged nanoparticles loaded
inside the vesicles will cause the Zeta potential values to
become intuitively less negative.
Figure 4 shows Transmission Electron Micrographs of
MCF7 and MCF10A cells after incubated with iron oxide
nanoparticles for different time lengths and these images
verified that both cells internalized iron oxide nanoparticles
through vesicular transport. Figure 4(a) shows that after
30 min incubation with MCF10A cells, a vesicle loaded
with iron oxide nanoparticles just formed. Multiple vesicles
containing iron oxide nanoparticles were observed within
the cell cytoplasm in Fig. 4(b) after 4 h and Fig. 4(c) after
24 h. For MCF7 cells, they might have a slower uptake
compared to MCF10A cells. Figure 4(d) and (e) show that
iron oxide nanoparticles still bind on the cell surface after
30 min and 4 h, which might be the reason why the Zeta
potential of MCF7 cells dropped significantly compared to
MCF10A cells. Figure 4 (f) shows that multiple vesicles
were also formed within the MCF7 cell cytoplasm after
24 h. From the images we got, the average size of the
vesicles formed in MCF7 cells is bigger than that of
MCF10A cells, as well as the number of iron oxide
nanoparticles inside each vesicle are much more than that
of MCF10A cells. These indicate the specific cell function-
ality between normal and cancer breast cells. Nanoparticles
didn’t enter mitochondria or cell nucleus from the TEM
images we got. Figure 5(a) and (b) show the Transmission
Electron Micrographs of MCF10A cells and MCF7 cells
after incubated with CPMV nanoparticles for 24 h respec-
tively. From these two images, we observed huge vesicles
were formed in both type of cells. For MCF10A cells
(Fig. 5(a)), the vesicle was filled with basically clustered
CPMV nanoparticles whereas fractured CPMV nanopar-
Fig. 4 Transmission Electron
Micrographs of MCF10A cells
that were incubated with iron
oxide nanoparticles for 30 min
(a), 4 h (b) and 24 h (c) at 37°C.
Transmission Electron Micro-
graphs of MCF7 cells that were
incubated with iron oxide nano-
particles for 30 min (d), 4 h (e)
and 24 h (f) at 37°C. All slices
were treated with uranyl acetate
to stain membranes and lead
citrate to stain the nuclear body.
Colored arrows represent se-
lected cell organelles: nuclei
(yellow), neucleolus (green),
mitochondria (blue), and
vesicles with iron oxide nano-
particles inside (red), filaments
(purple)
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ticles filled the vesicle inside MCF7 cells (Fig. 5(b)). This
fact also indicates the specific cell functionality between
normal and cancer breast cells.
Since iron oxide nanoparticles and CPMV nanoparticles
are all negatively charged on the surface, electrostatic
repulsion between anionic nanoparticles and negatively
charged cell membrane should repel the uptake of nano-
particles. As we have observed nanoparticle endocytosis
from the TEM images, the uptake of iron oxide nano-
particles and CPMV nanoparticles by cells could be
mediated by certain proteins despite their negative surface
charge. Nonspecific adsorption of proteins on the iron
oxide nanoparticle surface from cell culture medium will
induce the uptake of nanoparticles via receptor-mediated
cell endocytosis like other oxide and metal nanoparticles
did (Limbach et al. 2005; Wilhelm et al. 2002; Chithrani
et al. 2006). The agglomeration of iron oxide nanoparticles
after incubated with cells that we observed in TEM images
may also be caused by smaller surface charge after protein
adsorption and the repulsive forces by negatively charged
cell surface. The uptake mechanism of CPMV nanoparticle
by human cells is little known, but a recent study of CPMV
have identified a mediated endocytosis of CPMV via a
54 kD protein found on the plasma membrane of both
human and muring cell lines (Koudelka et al. 2007).
Figure 6 reveals the changes of Zeta potential values
with theoretical fittings for MCF10A normal cells and
MCF7 cancer cells after incubated with iron oxide and
CPMV nanopaticles. In general, the Zeta potential of MCF7
cells decreased after incubated with these two kinds of
nanoparticles compared to the increase of Zeta potential of
MCF10A cells. The Zeta potential of MCF7 cells became
more negative after incubated with nanoparticles, which
might be due to the dominant binding effect of nano-
particles on the cell surface membrane. This is consistent
with the significant drop of Zeta potential value of MCF7
cells after the first 30 min of incubation. The accumulation
of nanoparticles for longer time periods over the cell
surface and slower endocytosis observed in MCF7 cancer
cells experiments may suggest that the effect of nano-
particle binding was more dominant compared to internal-
ization process, which including the loss of negatively
charged plasma membrane of MCF7 cells and anionic
Fig. 5 (a) Transmission Electron Micrographs of MCF10A cells that
were incubated with CPMV-T184C nanoparticles for 24 h at 37°C. *
(b) Transmission Electron Micrographs of MCF7 cells that were
incubated with CPMV nanoparticles for 24 h at 37°C. Colored arrows
represent selected cell organelles: nuclei (yellow),vesicles with CPMV
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Fig. 6 Zeta potential change
with theoretical fitting for
MCF10A cells and MCF7 cells
after incubated with iron oxide
and CPMV nanopaticles for
30 min, 4 and 24 h. The zeta
potential of MCF7 cells de-
creased after incubated with
nanoparticles in contrary to a
trend of increase for MCF10A
cells after incubated with nano-
particles. The x axis for time
length used a logarithm scale
Biomed Microdevices (2008) 10:321–328 327
nanoparticles after endocytosis. However, for MCF10A
cells, nanoparticles were more actively internalized, hence
the internalization effect may dominate and finally cause
the zeta potential to increase. The surface charge of cells
over time is affected by the whole nanoparticle uptake
process and which is reflected in the changes of zeta
potential values after incubated with nanoparticles for
different time lengths.
From Fig. 6, similar patterns are observed for the same
type of cell after incubated with two different nanoparticles.
For oxide nanoparticles, protein adsorption will significant-
ly affect surface charge and shift the zeta potential to a
much smaller negative value after mixed with cell culture
medium (Limbach et al. 2005). Although iron oxide
nanoparticles alone has a much lower Zeta potential value
of −40.91±0.14 mV compared to −13.45±2.81 mV of
CPMV nanopaticles alone, after incubated with cells, iron
oxide nanoparticles should have adsorpted proteins on their
surfaces and their surface charge became close to CPMV
nanopaticles. That may be the reason that the Zeta potential
value change is similar instead of a big difference for two
different nanoparticles.
5 Conclusions
In conclusion, the Zeta potential change of cells after
incubated with nanoparticles is determined by a combina-
tion of binding effect and internalization effect to the
overall nanoparticles uptake process. The surface charge of
cells, the surface charge of nanoparticles and the interaction
between cells and nanoparticles led to distinct patterns in
Zeta potential measurements between normal breast cells
(MCF10A) and cancer breast cells (MCF7). This indicate
that Zeta potential may not only provide an insight into the
nature of the cellular interaction with nanoparticles, but also
can be utilized as a more streamlined method for probing
the nature of specific normal and cancer cells responses
with potential nanoparticle-based methods of diagnosis and
therapeutics. This is the first attempt to use Zeta potential
measurements as a cellular signature to study surface
interaction and cellular uptake of nanoparticles.
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